DermBiont

DermBiont, Inc. is a biotechnology company focused on developing skin microbial therapeutics aimed at treating, curing, and preventing various skin diseases. Founded in 2017 and headquartered in Boston, Massachusetts, with an additional office in Emeryville, California, the company operates at the intersection of dermatology and the microbiome. DermBiont harnesses naturally occurring skin microbes that have evolved over millennia to combat pathogenic microorganisms, including fungi and bacteria. Its clinical-stage pipeline includes innovative topical treatments for conditions such as seborrheic keratoses and melasma. By leveraging its extensive skin microbiome library and development capabilities, DermBiont aims to provide effective therapeutics with well-defined mechanisms of action, demonstrating safety and efficacy in its formulations.